1Rosenfeld MR, Pruitt AA. Management of malignant glio- mas and primary CNS lymphoma: standard of care and future directions [J]. Continuum (Minneap Minn), 2012, 18 (2): 406-415.
2Ignatova TN, Kukekov VG, Laywell ED, et al. Human cortical glial tumors contain neural stem-like cells expres- sing astroglial and neuronal markers in vitro [J]. Glia, 2002, 39(3): 193-206.
3Khoshnevisan A. An overview of therapeutic approaches to brain tumor stem cells [J]. Med J Islam Repub Iran, 2012, 26(1): 31-40.
5Lathia JD, Heddleston JM, Venere M, et al. Deadly team- work: neural cancer stem cells and the tumor microen- vironment [J]. Cell Stem Cell, 2011, 8(5): 482-485.
6Hemmanti HD, Nakano I, Lazareff JA, et al. Cancerous stem cells can arise from pediatric brain tumors [J]. Proc Natl Acad Sci USA, 2003, 100(25): 15178-15183.
7Singh SK, Hawkins C, Clarke ID, etl. Identification of human brain turnout initiating cells [J]. Nature, 2004, 432 (7015): 396-401.
8Hide T, Takezaki T, Nakamura H, et al. Brain tumor stem cells as research and treatment targets [J]. Brain Tumor Pathol, 2008, 25(2): 67-72.
9Liu G, Yuan X, Zeng Z, et al. Analysis of gene expression and chemoresistanee of CD133+ cancer stem cells in glioblastoma [J]. Mol Cancer, 2006, 5: 67.
10Nelson R. Brain-cancer stern cells may drive tumour for- mation [J]. L~mcet Neurol, 2005, 4(1): 17.
2Bach P, Abel T, Hoffmann C, et al. Specific elimination of CD133+ tumor cells with targeted oncolytic measles virus [J]. Cancer Res, 2013, 73(2): 865-874.
3Campos B, Herold-Mende CC. Insight into the complex regulation of CD133 in glioma [J]. Int J Cancer, 2011, 128 (3): 501-510.
4He J, Shan Z, Li L, et al. Expression of glioma stem cell marker CD133 and O6-methylguanine-DNA methyltrans- ferase is associated with resistance to radiotherapy in gliomas [J]. Oncol Rep, 2011, 26(5): 1305-1313.
5Read TA, Fogarty MP, Markant SL, et ol. Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma [J]. Cancer Cell, 2009, 15(2): 135-147.
6Kim led, Lee KH, Kim HS, et al. The presence of stem cell marker-expressing cells is not proguostically significant in glioblastomas [J]. Neuropathology, 2011, 31(5): 494-502.
7Son MJ, Woolard K, Nam DH, et al. SSEA-1 is an enrich- ment marker for tumor-initiating cells in human glio- blastoma [J]. Cell Stem Cell, 2009, 4(5): 440-452.
8Wan F, Herold-Mende C, Campos B, et al. Association of stem cell-related markers and survival in astrocytic gliomas [J]. Biomarkers, 2011, 16(2): 136-143.
9Sakurada K, Saino M, Mouri W, et al. Nestin expression in central nervous system germ cell tumors [J]. Neurosurg Rev, 2008, 31(2): 173-177.
10Beier D,Schulz JB,Beier CP.Chemoresistance of glioblastoma cancer stem cells--much more complex than expected[J].Mol Cancer,2011,10:128.
